Hydroxychloroquine (Plaquenil)

Category:

  • Antimalarial

Description:

  • 4- aminoquinoline

Indications:

  • Malaria prophylaxis

  • Malaria treatment

  • Lupus Erythematosus and Rheumatoid Arthritis

Contraindications:

  • Retinal or visual field changes of any etiology

Precautions:

  • Pregnancy category C

  • Take with food or milk to decrease gastrointestinal side effects.

  • Report signs of “chinconism” (tinnitis, headache, nausea, vision changes)

  • Dosages expressed in form of Hydroxychloroquine base:

    • Hydroxychloroquine Sulfate 200mg = Hydroxychloroquine base 60mg

Adverse Reactions (Side Effects):

  • Gastrointestinal: nausea, vomiting, anorexia, stomach pain

  • Chinconism

  • Muscle pain

  • Rash  

Dosage:

  • Administered orally

  • Dosages listed in Hydroxychloroquine base strength (HB)

  • Malaria prophylaxis:

    • Begin treatment 1-2 weeks prior, during and 4 weeks post travel to endemic area

    • Administer dose on same day every week

    • Adult: 310mg HB once every week

    • Child: (dosed per age or weight (5mg HB per kg)

      • < 1 year old: 37.5mg HB

      • 1-3 years old: 75mg HB

      • 4-6 years old: 100mg HB

      • 7-10 years old: 150mg HB

      • 11-16 years old: 225mg HB

  • Malaria treatment:

    • Initial dose:

      • Adult: 620mg CB

      • Child: 10mg/kg

    • Second dose (6 hours later)

      • Adult: 310mg CB

      • Child: 5mg/kg CB

    • Doses days 2 & 3:

      • Adult: 310mg CB

      • Child: 5mg/kg CB

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site